|
|
Blood, 2 April 2009, Vol. 113, No. 14, pp. 3333-3336.
Prepublished online as a Blood First Edition Paper on February 4, 2009; DOI 10.1182/blood-2008-11-187302.
Previous Article | Next Article 
Submitted November 3, 2008
Accepted January 16, 2009
Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response
Aaron F. Carlin, Satoshi Uchiyama, Yung-Chi Chang, Amanda L. Lewis, Victor Nizet, and Ajit Varki*
Departments of Medicine, Pediatrics and Cellular & Molecular Medicine, University of California, San Diego, La Jolla, CA, United States
* Corresponding author; email: a1varki{at}ucsd.edu.
Human neutrophil Siglec-9 is a lectin that recognizes sialic acids (Sias) via an amino-terminal V-set Ig domain and possesses tyrosine-based inhibitory motifs in its cytoplasmic tail. We hypothesized that Siglec-9 recognizes host Sias as "self", including in cis interactions with Sias on the neutrophil's own surface, thereby dampening unwanted neutrophil reactivity. Here we show that neutrophils presented with immobilized multimerized Sia 2-3Gal 1-4GlcNAc- units engage them in trans via Siglec-9. The sialylated capsular polysaccharide (CPS) of Group B Streptococcus (GBS) also presents terminal Sia 2-3Gal 1-4GlcNAc- units, and similarly engages neutrophil Siglec-9, dampening neutrophil responses in a Sia- and Siglec-9-dependent manner. Reduction in the neutrophil oxidative burst, diminished formation of neutrophil extracellular DNA traps ("NETs"), and increased bacterial survival are also facilitated by GBS sialylated CPS interactions with Siglec-9. Thus, GBS can impair neutrophil defense functions by co-opting a host inhibitory receptor via sialoglycan molecular mimicry, a novel mechanism of bacterial immune evasion.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Weiman, S. Dahesh, A. F Carlin, A. Varki, V. Nizet, and A. L Lewis
Genetic and biochemical modulation of sialic acid O-acetylation on group B Streptococcus: Phenotypic and functional impact
Glycobiology,
November 1, 2009;
19(11):
1204 - 1213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Lewis, N. Desa, E. E. Hansen, Y. A. Knirel, J. I. Gordon, P. Gagneux, V. Nizet, and A. Varki
Innovations in host and microbial sialic acid biosynthesis revealed by phylogenomic prediction of nonulosonic acid structure
PNAS,
August 11, 2009;
106(32):
13552 - 13557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. F. Carlin, Y.-C. Chang, T. Areschoug, G. Lindahl, N. Hurtado-Ziola, C. C. King, A. Varki, and V. Nizet
Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5
J. Exp. Med.,
August 3, 2009;
206(8):
1691 - 1699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Varki
Natural ligands for CD33-related Siglecs?
Glycobiology,
August 1, 2009;
19(8):
810 - 812.
[Full Text]
[PDF]
|
 |
|
|
|